Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biofrontera Inc. Director's Dealing 2026

Mar 7, 2026

35198_dirs_2026-03-06_1d7059bb-63fa-4c58-ab74-e11be75b3c4d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Biofrontera Inc. (BFRI)
CIK: 0001858685
Period of Report: 2026-03-04

Reporting Person: BORER JOHN J III (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-03-04 Employee stock option (right to buy) $0.90 A 20000 Acquired 2036-03-04 Common Stock (20000) Direct

Footnotes

F1: The option vests in twelve equal monthly instalments beginning on April 4, 2026.

F2: Options with different terms are not included.